Professional Documents
Culture Documents
BCG COVID-19 India Perspective PDF
BCG COVID-19 India Perspective PDF
India Perspective
20 MARCH 2020
Global Overview
• COVID-19 confirmed cases accelerating exponentially in several epicenters, particularly
Europe and North America; Spread to 160 countries now
• Global equity markets have aggressively reacted to virus' spread beyond China with 30-
35% erosion in value since past 4 weeks; S&P500 saw the fastest 10% fall from the peak
Executive in a week
• Many countries, including India, have imposed travel and assembly restrictions, non-
summary essential business closures to contain the spread
• Industries are getting differently impacted by COVID-19, though too early to call.
Pharma, Digital Media, Consumer-staples protected so far, some others, such as Travel
& tourism, Entertainment, Automotive, Durables, Consumer-discretionary, etc. are
seeing significant disruptions. Second order effects started to play out
1
Emerging Macro-scenarios
• COVID-19 impact and recovery scenarios are changing by the day; Three potential
scenarios could emerge - Rapid recovery (V) or Slow comeback (U) or Protracted
challenge (L) driven by 1. Evolving properties of the virus, 2. Containment & mitigation
efforts, 3. Treatment / vaccine development lead-time, 4. Policy & fiscal response
Executive • Significant uncertainty around the geometry and intensity of the shock
• COVID-19 scenario is unprecedented - high contagious rate (vs. earlier flus), large scale
3
Global overview
4
Data as of 19 Mar
Total Cases
244K
Greater China registered
Italy
Spain
Germany USA
10,000 South Korea
France
0 Feb. 21
-5
-10
U.S. (S&P 500)
-10%
COVID
-20% 10/7/97 –
10/27/97
-30% 7/16/90 – 3/24/00 – 9/20/18-
10/11/90 10/9/02 12/24/18
-40% 11/28/80 – 10/9/89 – 7/16/99 –
8/12/82 1/30/90 10/15/99
-50% 2/13/80 – 1/26/18 –
10/10/83 – 8/25/87 – 7/17/98 – 10/9/07 – 5/21/15 –
2/8/18
3/27/80 7/24/84 12/4/87 8/31/98 3/9/09 2/11/16
2/19/20 – 3/18/20
Sensex drawdowns
0%
-20% COVID
-30%
-40%
Correction line (-10%) 12/27/02 – 1/15/08 – 5/21/15 –
-50% 3/31/03 3/31/09 2/12/16
Bear market line (-20%)
• COVID-19 drawdown from Feb 21st to 27th stands out as fastest 10% fall in the S&P 500 index from peak
• Market has continued to decline due to COVID-19, at a much faster pace on both indexes than SARS
(2002); it is comparable with 2008 recession
Source: Bloomberg; BCG Center for Macroeconomics analysis 7
Data as of 19 Mar
Non- Non-
US announced ban on non-
essential International Internal essential
School Restricted business travel travel local citizen travel from EU
closure assembly closure restrictions restrictions movement countries; all federal
govt. bodies taking active
China
measures
Spain
France
Italy has expanded
Switzerland
lockdown to cover entire
Italy country and call on for
9
Indian GDP growth was slowing down
7.48
6.55 6.76
5.27
Note: Past year/quarter data may vary from the previous versions of the Economic Monitor owing to restating of previous years' data by the CMIE/reporting agencies
Recasts for the upcoming quarters (bar graph) and estimated overall growth rate (line graph)
Source: CMIE, BCG Analysis 10
Multiple indicators were showing early signs of recovery in Q4'19 &
early Q1'20
Exports & imports recovering in Steady growth observed in IIP Expansion in manufacturing &
Q4'19 after a 6 month slowdown since Q4'19 services PMI since Q4'19
Growth % IIP (Index) PMI
140 56
20
135 54
50
-20 0 0
Aug- Feb- Aug- Feb- Aug- Feb- Aug- Jan- Aug- Feb- Aug- Feb-
18 19 19 20 18 18 19 20 18 19 19 20
Source: CMIE 11
Data as of 19 Mar
COVID-19 hit India in Mar-20; cases are doubling every 5 days, with
majority of cases concentrated in 3 states
Total no. of incidents: 195
(incl. 32 foreign nationals)
2x Jammu and Ladakh (10)
No. of deaths: 4
Total confirmed cases of COVID-19, India 195
Kashmir (4)
(~2%; global avg. 4%)
Punjab (2)
• Out of these 195 cases, 20 have been
Chandigarh (1) Uttarakhand (1)
cured/discharged and 4 deaths 170
Haryana
Delhi (17) (17) Meghalaya
140 Uttar
Rajasthan Pradesh
2x (7) (19)
110 114
100
85 Chhattisgarh
2-Mar
3-Mar
4-Mar
5-Mar
6-Mar
7-Mar
8-Mar
9-Mar
10-Mar
11-Mar
12-Mar
13-Mar
14-Mar
15-Mar
16-Mar
17-Mar
18-Mar
19-Mar
Pondicherry (1)
Kerala Tamil Nadu (3) Andaman
(28) and Nicobar Islands
Source: Ministry of health website; Johns Hopkins CSSE, Ministry of health & family welfare, World Health organization, Economic times
12
Non exhaustive Data as of 19 Mar
Ban exercised on all international National lockdown 'Junta Curfew' All individuals requiring to be tested
commercial passenger flights; declared by PM Modi on 22 Mar are offered tests at no cost
• SpiceJet, Vistara, etc have Closure of all educational Kolkata Port to quarantine vessels
suspended their international establishments, gyms, museums, arriving from COVID-19 hit countries
operations cultural & social centers, swimming
pools & theatres initiated by states to Maharashtra, Karnataka, Delhi
Internal travel bans implemented by stamping people under home
declined,
spending Shopping Malls 20% decline in footfalls,
pattern
changed in past Apparel Stores 25% decline in footfalls,
recent shutdowns will lead to further decline
2-4 weeks
Entertainment 35% decline in sales,
recent shutdowns will lead to further decline
14
Press Reports, Secondary Research
Preliminary view Data as of 19 Mar
• Passenger Cars: Will remain sluggish due to • Restriction of parts from China and other severely
Auto postponement of purchase impacted countries will impact manufacturing
• Commercial Vehicles: uncertainty in demand • Possible shutdowns, reduction in production
• Economic fallout of shutdowns can create challenges
Financials • Limited supply side impact
for MSME/SME sector leading to new wave of NPAs
Source: Industry report analysis, Analyst reports, Press reports, BCG Analysis, Expert interviews 16
Emerging Macro-scenarios
17
Three macro-impact scenarios emerging under COVID-19
Multiple Evolving properties of the virus Containment & mitigation efforts
factors will
determine
scenarios Cure / vaccine development lead-time Policy & fiscal response
19
Source: U.S. Census, BEA, CDC, Census and Statistics Department (Hong Kong), BCG Center for Macroeconomics analysis
Significant uncertainty around the geometry and
intensity of the shock
Scenario description Scenario 1: Where it
Scenario 2: What we Scenario 3: Possible, not
seems to have already
are striving to avoid a foregone conclusion
Real GDP headed Duration of
Drawdown drawdown (Qtrs)
Where we 2. Strategic
1. Tactical call are now
(~0%) V U L 1Q
macro call
• i.e. "intensity" of
Intensity of shock
2001
400 400
Period of Critical Periods of disruption
Critical disruption care
care
cases / 200
cases / 200
100,000
100,000
Critical care capacity people Critical care capacity
people
0 0
Jan-20 Apr-20 Jul-20 Oct-20 Jan-21 Jan-20 Apr-20 Jul-20 Oct-20 Jan-21
Cure / vaccine • Significant policy response & fiscal support • Slow / unsuccessful treatment, or sustained effort
lead-time needed
• Single main spike of infections with small • Repeated lock downs with only moderate return to
Containment &
mitigation manageable subsequent spikes normalcy in-between
efforts
• Rapid drive to vaccine/ effective treatment • Large scale unemployment leading to reduced income
and consumption
Policy & fiscal • Single lock down lasting for a short period, with a • Slow or insufficient policy response
response return to normal afterwards 21
Source: Imperial college paper, BCG analysis
Data as of 19 Mar
~160 Countries affected till date, globalization has lead to rapid spread
12-18
months
Lead-time expected for vaccines, no credible cure available today
Source: Press search, analyst reports; 1. R0: Avg. # of people infected by each sick person at the peak of transmission (when the susceptible population is at its greatest); Source: Bridgewater
22
Associates, National Health Commission China, American Journal of Epidemiology, US National Library of Medicine, BCG Henderson Institute analysis
the reality is
unknown …
24
Call for action: Act now, Prepare for near term, Build for medium term
Now: Medium-term:
Near-term:
Act on immediate Build structural competitive
Prepare for the rebound
priorities advantage
1 3 5 7
25
1.1 Mobilize senior team to act immediately
Identify a cross functional senior stakeholder team to set-up a
1.2 "rapid-response team" with clear decision rights to take control of
the situation led by CEO
1
1.3 Build a rapid response check-list and actively setup tracking
capabilities
1.4 Setup PMO to identify & monitor risks to business; Plan for
contingency
2
Accelerate smart work by arranging flexible working plans (rosters etc.)
2.4
for business continuity
Outreach to key accounts / customers to understand and address
2.5
consumer sentiments/ requirements
Assess potential impact of virus spread on company workforce and plan for
Safeguard 2.6 mitigations strategy (scenarios, training)
27
3.1 Establish liquidity office to forecast cash flows and manage/mitigate
risks
Ensure rigorous, prudent cash management and governance and
3.2
reduce non-critical uses of cash
Assess viability of current investment roadmaps and dividend policy
3.3
3
and share repurchase plans
Stress test cash-flow from financing / investing based on market
3.4 scenarios
Stress test the Engage with shareholders and clearly communicate action plans to key
28
Establish demand-side rapid response team to monitor marketing,
4.1 sales and pricing implications
4
needs
4.7 Craft new product and service story and create new selling points,
cautiously select marketing channels during epidemic
4.8 Look for new channels and new disruptive formats that work under
epidemic
30
6.1 Set up an operational core team to create transparency (e.g. along supply
chain)
6.3 Adjust inventory in real time, reshuffle to new reality, avoid inventory glut
6
Understand liquidity & business position of key suppliers and associated risks
6.4 • Identify alternative suppliers for critical components, plan for changing
lead times and re-route logistics
• Set up dedicated funding or adjust trade terms to address cash flow
concerns of suppliers
7
operational, and financial decision-making
Restructure,
32
Engage as a partner
We will partner with you in getting the rapid response team kick-
started with an agile working model
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have
taken great care prior to producing this presentation, it represents BCG’s view at a particular point in
time. This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute
for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As
such you are advised to make your own assessment as to the appropriate course of action to take, using
this presentation as guidance. Please carefully consider local laws and guidance in your area,
34
The services and materials provided by Boston Consulting Group (BCG) are subject to BCG's Standard Terms
(a copy of which is available upon request) or such other agreement as may have been previously executed by BCG.
BCG does not provide legal, accounting, or tax advice. The Client is responsible for obtaining independent advice
concerning these matters. This advice may affect the guidance given by BCG. Further, BCG has made no undertaking
to update these materials after the date hereof, notwithstanding that such information may become outdated
or inaccurate.
The materials contained in this presentation are designed for the sole use by the board of directors or senior
management of the Client and solely for the limited purposes described in the presentation. The materials shall not be
copied or given to any person or entity other than the Client (“Third Party”) without the prior written consent of BCG.
These materials serve only as the focus for discussion; they are incomplete without the accompanying oral commentary
and may not be relied on as a stand-alone document. Further, Third Parties may not, and it is unreasonable for any
Third Party to, rely on these materials for any purpose whatsoever. To the fullest extent permitted by law (and except
to the extent otherwise agreed in a signed writing by BCG), BCG shall have no liability whatsoever to any Third Party,
and any Third Party hereby waives any rights and claims it may have at any time against BCG with regard to the
services, this presentation, or other materials, including the accuracy or completeness thereof. Receipt and review of
this document shall be deemed agreement with and consideration for the foregoing.
35
bcg.com